Viridian Therapeutics, Inc.\DE (VRDN)
CIK 1590750 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Viridian Therapeutics, Inc.\DE.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 20, 2026 | SCHEDULE 13G | 0000919574-26-005637 |
| Aug 20, 2026 | 4 | 0001193125-26-359636 |
| Aug 19, 2026 | 144 | 0001959173-26-006222 |
| Aug 18, 2026 | 4 | 0001193125-26-355735 |
| Aug 14, 2026 | SCHEDULE 13G | 0000080255-26-000556 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0001907884-26-000016 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0001104659-26-097208 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0001172661-26-003486 |
| Aug 7, 2026 | SCHEDULE 13G | 0000093751-26-000558 |
| Aug 6, 2026 | 8-K | 0001193125-26-336691 |
| Aug 6, 2026 | 10-Q | 0001590750-26-000018 |
| Jul 2, 2026 | 4 | 0001193125-26-294556 |
| Jul 2, 2026 | 4 | 0001193125-26-294552 |
| Jul 2, 2026 | 4 | 0001193125-26-294560 |
| Jul 2, 2026 | 4 | 0001193125-26-294546 |
| Jul 2, 2026 | 4 | 0001193125-26-294561 |
| Jul 2, 2026 | 4 | 0001193125-26-294547 |
| Jun 29, 2026 | 8-K | 0001193125-26-286273 |
| Jun 26, 2026 | SCHEDULE 13G | 0001104659-26-078245 |
| Jun 3, 2026 | 8-K | 0001193125-26-254560 |
| May 28, 2026 | 8-K | 0001193125-26-245186 |
| May 26, 2026 | 8-K | 0001193125-26-239246 |
| May 15, 2026 | SCHEDULE 13G | 0001104659-26-062332 |
| May 13, 2026 | 4 | 0001104659-26-060294 |
| May 13, 2026 | SCHEDULE 13D/A | 0001104659-26-060292 |